Browsing School of Medicine (MU) by Title "How do these 3 diabetes agents compare in reducing mortality?"

Now showing items 1-1 of 1

  • How do these 3 diabetes agents compare in reducing mortality? 

    Martini, Jennifer; Coe, Catherine L.; Mounsey, Anne (Family Physicians Inquiries Network, 2019)
    How do these 3 diabetes agents compare in reducing mortality? A meta-analysis reveals that there may be advantages associated with SGLT-2 inhibitors and GLP-1 agonists that are not associated with DPP-4 inhibitors. PRACTICE ...